In conclusion, present results indicate that the IHC evaluation of E-cadherin expression in terms of negative/positive status should perhaps be too naive as E-cadherin positivity might actually hide complex biological interactions that may determine the course of tumour progression and disease outcome. The gene discussed is CDH1; the disease is neoplasm.